Concentrix is trading at $29.01, up +5.38% on September 22, 2026, after rebounding from its recent fiscal-year guidance reduction.
- Management lowered fiscal 2026 adjusted EPS guidance to $10.83–$11.18 and revenue guidance to $9.93–$10.03 billion, below cited analyst expectations.
- Fiscal third-quarter revenue is expected at $2.465–$2.490 billion.
- Shares are recovering despite the reduced outlook, with no major macro catalyst identified.